Skip to main content

Advertisement

Log in

Fertility preservation practices for female oncofertility differ significantly across the USA: results of a survey of SREI members

  • Fertility Preservation
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Purpose

The field of oncofertility has maintained an important focus on improving access, yet standardized practices are lacking. To assess how female cancer patients are provided oncofertility care, we sought to determine provider-level differences and whether there are physician or practice characteristics that predict these variations.

Methods

A cross-sectional survey was sent to SREI members. The survey included fifteen questions about physician practice characteristics and oncofertility cryopreservation protocols. Topics included ovarian stimulation protocols, fertilization techniques, stage of embryo cryopreservation, routine use of pre-implantation genetic testing for aneuploidy (PGT-A), and ovarian tissue cryopreservation (OTC). Statistical analyses assessed whether practice setting, geographic region, time in practice, and mandatory state insurance coverage had effects on cryopreservation protocols.

Results

A total of 141 (17%) from diverse REI practice backgrounds completed the survey. The median number of new female oncofertility consults per year was 30 (range 1 to 300). Providers in academic settings treated more patients (median 40 vs. 15, p < 0.001). Providers in academic settings more often use gonadotropin-releasing hormone agonists (85% vs. 52%, p < 0.001) and perform OTC (41% vs. 4%, p < 0.001). Providers in academic practices were less likely to perform intracytoplasmic sperm injection in every cycle (37% vs. 55%, p = 0.032) and less likely to usually advise PGT-A (21% vs. 36%, p = 0.001). Mandated state insurance coverage had no effect on oncofertility practices.

Conclusion

Oncofertility practices vary among providers. Factors such as practice setting and region may affect the services provided. We do not yet know the best practices in oncofertility patients, and future research is needed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Oktay K, Harvey BE, Partridge AH, et al. Fertility preservation in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol. 2018;36(19):1994–2001. https://doi.org/10.1200/JCO.2018.78.1914.

    Article  PubMed  Google Scholar 

  2. Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Fertil Steril. 2019;112(6):1022–1033. https://doi.org/10.1016/j.fertnstert.2019.09.013

  3. Al-Azawi T, Tavukcuoglu S, Khaki AA, Al HS. Cryopreservation of human oocytes, zygotes, embryos and blastocysts: a comparison study between slow freezing and ultra rapid (vitrification) methods. Middle East Fertil Soc J. 2013;18(4):223–32. https://doi.org/10.1016/j.mefs.2012.10.008.

    Article  Google Scholar 

  4. Intracytoplasmic sperm injection (ICSI) for non-male factor infertility: a committee opinion. Fertil Steril. 2012;98(6):1395–1399. https://doi.org/10.1016/j.fertnstert.2012.08.026

  5. Elnahas A, Alcolak E, Marar EA, et al. Vitrification of human oocytes and different development stages of embryos: An overview. Middle East Fertil Soc J. 2010;15(1):2–9. https://doi.org/10.1016/j.mefs.2010.03.013.

    Article  Google Scholar 

  6. Al-Hasani S, Ozmen B, Koutlaki N, Schoepper B, Diedrich K, Schultze-Mosgau A. Three years of routine vitrification of human zygotes: is it still fair to advocate slow-rate freezing? Reprod Biomed Online. 2007;14(3):288–93. https://doi.org/10.1016/S1472-6483(10)60869-3.

    Article  PubMed  Google Scholar 

  7. Veeck LL. Does the developmental stage at freeze impact on clinical results post-thaw? Reprod Biomed Online. 2003;6(3):367–74. https://doi.org/10.1016/S1472-6483(10)61859-7.

    Article  PubMed  Google Scholar 

  8. Marek D, Langley M, Gardner DK, Confer N, Doody KM, Doody KJ. Introduction of blastocyst culture and transfer for all patients in an in vitro fertilization program. Fertil Steril. 1999;72(6):1035–40. https://doi.org/10.1016/S0015-0282(99)00409-4.

    Article  CAS  PubMed  Google Scholar 

  9. Humphreys M, Johnstone E, Letourneau JM. Current approaches to fertility preservation. Clin Obstet Gynecol. 2020;63(4):735–51. https://doi.org/10.1097/GRF.0000000000000574.

    Article  PubMed  Google Scholar 

  10. Coyne K, Purdy M, Oâ€TMLeary K, Yaklic JL, Lindheim SR, Appiah LA. Challenges and considerations in optimizing ovarian stimulation protocols in oncofertility patients. Front Public Health. 2014;2. https://doi.org/10.3389/fpubh.2014.00246

  11. Donnez J, Dolmans MM. Fertility preservation in women. Campion EW, ed. N Engl J Med. 2017;377(17):1657–1665. https://doi.org/10.1056/NEJMra1614676

  12. Keros V, Xella S, Hultenby K, et al. Vitrification versus controlled-rate freezing in cryopreservation of human ovarian tissue. Hum Reprod. 2009;24(7):1670–83. https://doi.org/10.1093/humrep/dep079.

    Article  CAS  PubMed  Google Scholar 

  13. Dolmans MM, Donnez J. Fertility preservation in women for medical and social reasons: oocytes vs ovarian tissue. Best Pract Res Clin Obstet Gynaecol. 2021;70:63–80. https://doi.org/10.1016/j.bpobgyn.2020.06.011.

    Article  PubMed  Google Scholar 

  14. Dolmans MM, von Wolff M, Poirot C, et al. Transplantation of cryopreserved ovarian tissue in a series of 285 women: a review of five leading European centers. Fertil Steril. 2021;115(5):1102–15. https://doi.org/10.1016/j.fertnstert.2021.03.008.

    Article  CAS  PubMed  Google Scholar 

  15. Eliner Y, Palmor M, Amaral B, Penzias AS, Sakkas D, Vaughan DA. Does pgt-a shorten time to live birth? The use of propensity score matching to compare pgt-a versus non-pgt-a patients. Fertil Steril. 2021;116(3, Supplement):e180. https://doi.org/10.1016/j.fertnstert.2021.07.493

  16. Ulrich ND, Raja NS, Moravek MB. A review of fertility preservation in patients with breast cancer. Best Pract Res Clin Obstet Gynaecol. Published online January 2022:S1521693422000116. https://doi.org/10.1016/j.bpobgyn.2022.01.004

  17. Kawwass JF, Shandley LM, Boulet SL, Hipp HS. Oncologic oocyte cryopreservation: national comparison of fertility preservation between women with and without cancer. J Assist Reprod Genet. 2020;37(4):883–90. https://doi.org/10.1007/s10815-020-01715-8.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Quinn MM, Cakmak H, Letourneau JM, Cedars MI, Rosen MP. Response to ovarian stimulation is not impacted by a breast cancer diagnosis. Hum Reprod. Published online January 24, 2017:humrep;dew355v1. https://doi.org/10.1093/humrep/dew355

  19. Cobo A, García-Velasco J, Domingo J, Pellicer A, Remohí J. Elective and onco-fertility preservation: factors related to IVF outcomes. Hum Reprod. 2018;33(12):2222–31. https://doi.org/10.1093/humrep/dey321.

    Article  CAS  PubMed  Google Scholar 

  20. Turan V, Quinn MM, Dayioglu N, Rosen MP, Oktay K. The impact of malignancy on response to ovarian stimulation for fertility preservation: a meta-analysis. Fertil Steril. 2018;110(7):1347–55. https://doi.org/10.1016/j.fertnstert.2018.08.013.

    Article  PubMed  Google Scholar 

  21. Chang EM, Song HS, Lee DR, Lee WS, Yoon TK. In vitro maturation of human oocytes: its role in infertility treatment and new possibilities. Clin Exp Reprod Med. 2014;41(2):41. https://doi.org/10.5653/cerm.2014.41.2.41.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Walls ML, Hart RJ. In vitro maturation. Best Pract Res Clin Obstet Gynaecol. 2018;53:60–72. https://doi.org/10.1016/j.bpobgyn.2018.06.004.

    Article  PubMed  Google Scholar 

  23. Shapira M, Dolmans MM, Silber S, Meirow D. Evaluation of ovarian tissue transplantation: results from three clinical centers. Fertil Steril. 2020;114(2):388–97. https://doi.org/10.1016/j.fertnstert.2020.03.037.

    Article  PubMed  Google Scholar 

  24. State Laws & Legislation. Alliance for fertility preservation. Accessed 10 April 2022. https://www.allianceforfertilitypreservation.org/state-legislation/

  25. 2019 Assisted reproductive technology fertility clinic and national summary report. Published online 2019:112.

  26. Stadtmauer L, Amato P, Sadek S, McGee EA, Rossi B, Hurst BS. Survey of current practice and satisfaction of SREI members: an SREI committee report. Fertil Steril. 2020;114(3): e70. https://doi.org/10.1016/j.fertnstert.2020.08.215.

    Article  Google Scholar 

  27. Barnhart KT, Nakajima ST, Puscheck E, Price TM, Baker VL, Segars J. Practice patterns, satisfaction, and demographics of reproductive endocrinologists: results of the 2014 Society for Reproductive Endocrinology and Infertility Workforce Survey. Fertil Steril. 2016;105(5):1281–6. https://doi.org/10.1016/j.fertnstert.2015.12.135.

    Article  PubMed  Google Scholar 

  28. Omurtag K, Grindler NM, Roehl KA, et al. How members of the Society for Reproductive Endocrinology and Infertility and Society of Reproductive Surgeons evaluate, define, and manage hydrosalpinges. Fertil Steril. 2012;97(5):1095-1100.e2. https://doi.org/10.1016/j.fertnstert.2012.02.026.

    Article  PubMed  Google Scholar 

  29. Stanitis JA, Grow DR, Wiczyk H. Fertility services for human immunodeficiency virus–positive patients: provider policy, practice, and perspectives. Fertil Steril. 2008;89(5):1154–8. https://doi.org/10.1016/j.fertnstert.2007.05.017.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by LC and JL. The first draft of the manuscript was written by LC. All authors commented on previous versions of the manuscript and read and approved the final manuscript.

Corresponding author

Correspondence to Leah J. Cooper.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 98 KB)

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cooper, L.J., Emery, B.R., Aston, K. et al. Fertility preservation practices for female oncofertility differ significantly across the USA: results of a survey of SREI members. J Assist Reprod Genet 39, 1749–1757 (2022). https://doi.org/10.1007/s10815-022-02567-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10815-022-02567-0

Keywords

Navigation